{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T21:47:03Z","timestamp":1787435223115,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017244","name":"Harvard-MIT Center for Regulatory Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017244","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014848","name":"Arnold Ventures LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014848","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.josat.2023.209243","type":"journal-article","created":{"date-parts":[[2023,12,3]],"date-time":"2023-12-03T23:45:33Z","timestamp":1701647133000},"page":"209243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Rates and costs of drug testing practices for private payors in the outpatient setting in the United States, 2015\u20132019"],"prefix":"10.1016","volume":"159","author":[{"given":"Rachel E.","family":"Barenie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T.","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary S.","family":"Connery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore","family":"Tsacogianis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron S.","family":"Kesselheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2023.209243_bb0005","author":"American Society of Addiction Medicine"},{"key":"10.1016\/j.josat.2023.209243_bb0010","unstructured":"American Society of Addiction Medicine. (2019, December 18) National practice guideline for the treatment of opioid use disorder, 2020 focused update. Available at: https:\/\/sitefinitystorage.blob.core.windows.net\/sitefinity-production-blobs\/docs\/default-source\/guidelines\/npg-jam-supplement.pdf?sfvrsn=a00a52c2_2."},{"issue":"2","key":"10.1016\/j.josat.2023.209243_bb0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11916-020-00918-z","article-title":"Review of the current state of urine drug testing in chronic pain: still effective as a clinical tool and curbing abuse, or an arcane test?","volume":"25","author":"Chakravarthy","year":"2021","journal-title":"Current Pain and Headache Report"},{"key":"10.1016\/j.josat.2023.209243_bb0020","author":"Cigna"},{"key":"10.1016\/j.josat.2023.209243_bb0025","author":"Commonwealth of Massachusetts Office of the State Auditor"},{"key":"10.1016\/j.josat.2023.209243_bb0030","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.2147\/JPR.S213536","article-title":"Increased frequency of urine drug testing in chronic opioid therapy: rationale for strategies for enhancing patient adherence and safety","volume":"12","author":"DiBenedetto","year":"2019","journal-title":"Journal of Pain Research"},{"issue":"RR-3","key":"10.1016\/j.josat.2023.209243_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC Clinical Practice Guideline for Prescribing Opioids for Pain \u2014 United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.josat.2023.209243_bb0040","article-title":"Drug screens raising revenue for rehabs, costs for patients","author":"Gentry","year":"2019","journal-title":"Health Care"},{"issue":"10","key":"10.1016\/j.josat.2023.209243_bb0045","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1001\/jamainternmed.2021.4109","article-title":"Reassessing the role of routine urine drug screening in opioid use disorder treatment","volume":"181","author":"Incze","year":"2021","journal-title":"JAMA Internal Medicine"},{"key":"10.1016\/j.josat.2023.209243_bb0050","author":"Laffer"},{"issue":"1","key":"10.1016\/j.josat.2023.209243_bb0055","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/08897077.2015.1110742","article-title":"Predictors of urine drug testing for patients with chronic pain: Results from a national cohort of U.S. veterans","volume":"37","author":"Morasco","year":"2016","journal-title":"Substance Abuse"},{"key":"10.1016\/j.josat.2023.209243_bb0060","doi-asserted-by":"crossref","first-page":"388","DOI":"10.7326\/M22-2917","article-title":"The use of opioids in the management of chronic pain: Synopsis of the 2022 updated US Department of Veterans Affairs and US Department of Defense Clinical Practice Guideline","volume":"176","author":"Sandbrink","year":"2023","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.josat.2023.209243_bb0065","doi-asserted-by":"crossref","first-page":"633","DOI":"10.7326\/0003-4819-153-10-201011160-00005","article-title":"The epidemiology of prescriptions abandoned at the pharmacy","volume":"153","author":"Shrank","year":"2010","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.josat.2023.209243_bb0070","series-title":"Doctors make big money testing urine for drugs, then ignore abnormal results","author":"Shulte","year":"2017"},{"key":"10.1016\/j.josat.2023.209243_bb0075","series-title":"Federal suit alleges \u2018staggering\u2019 urine drug testing fraud at Tennessee pain clinics","author":"Shulte","year":"2019"},{"issue":"2","key":"10.1016\/j.josat.2023.209243_bb0080","first-page":"E249","article-title":"Trends in urine drug monitoring among persons receiving long-term opioids and persons with opioid use disorder in the United States","volume":"24","author":"Sohn","year":"2021","journal-title":"Pain Physician"},{"key":"10.1016\/j.josat.2023.209243_bb0085","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.josat.2023.209243_bb0090","author":"Substance Abuse and Mental Health Services Administration"},{"issue":"4","key":"10.1016\/j.josat.2023.209243_bb0095","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.amepre.2020.10.011","article-title":"Trends in urine drug testing among long-term opioid users, 2012\u20132018","volume":"60","author":"Taha","year":"2021","journal-title":"American Journal of Preventive Medicine"},{"key":"10.1016\/j.josat.2023.209243_bb0100","author":"Tennessee Department of Health"},{"key":"10.1016\/j.josat.2023.209243_bb0105","author":"Tennessee Department of Health"},{"key":"10.1016\/j.josat.2023.209243_bb0110","author":"U.S. Department of Justice"},{"issue":"1\u20132","key":"10.1016\/j.josat.2023.209243_bb0115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drugalcdep.2013.02.018","article-title":"Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: Systematic review","volume":"131","author":"van Boekel","year":"2013","journal-title":"Drug and Alcohol Depend"},{"issue":"4","key":"10.1016\/j.josat.2023.209243_bb0120","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/pm\/pnz356","article-title":"Understanding buprenorphine for use in chronic pain: Expert opinion","volume":"21","author":"Webster","year":"2020","journal-title":"Pain Medicine"},{"issue":"1","key":"10.1016\/j.josat.2023.209243_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00952990.2018.1546862","article-title":"Development of a cascade of care for responding to the opioid epidemic","volume":"45","author":"Williams","year":"2019","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"2","key":"10.1016\/j.josat.2023.209243_bb0130","first-page":"111","article-title":"Observation of improved adherence with frequent urine drug testing in patients with pain","volume":"10","author":"Yee","year":"2014","journal-title":"Journal of Opioid Management"},{"key":"10.1016\/j.josat.2023.209243_bb0135","author":"21 CFR"},{"key":"10.1016\/j.josat.2023.209243_bb0140","author":"42 CFR"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923002941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923002941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T01:47:40Z","timestamp":1728611260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875923002941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":28,"alternative-id":["S2949875923002941"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2023.209243","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rates and costs of drug testing practices for private payors in the outpatient setting in the United States, 2015\u20132019","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2023.209243","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"209243"}}